Growth differentiation factor-5 (GDF5) regulates TGFβ-mediated pro-angiogenic signaling (Margheri et al., 2012), and its significant downregulation in the late stages here might set the stage for metastatic cancer. Here, GDF5 is linked to metastatic malignant neoplasm.